The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty

NCT02760979 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Bone Resorption

Interventions

DRUG: Denosumab
DRUG: Placebo

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau